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Abstract
Maternal undernutrition (MUN) during pregnancy may lead to fetal intrauterine growth restriction (IUGR), which
itself predisposes to adult risk of obesity, hypertension, and diabetes. IUGR may stem from insufficient maternal
nutrient supply or reduced placental nutrient transfer. In addition, a critical role for maternal stress-induced
glucocorticoids (GCs) has been suggested to contribute to both IUGR and the ensuing risk of adult metabolic
syndrome. While GC-induced fetal organ defects have been examined, there have been few studies on placental
responses to MUN-induced maternal stress. Therefore, we hypothesize that 50% MUN associates with increased
maternal GC levels and decreased placental HSD11B. This in turn leads to decreased placental and fetal growth,
hence the need to investigate nutrient transporters. We measured maternal serum levels of corticosterone, and the
placental basal and labyrinth zone expression of glucocorticoid receptor (NR3C1), 11-hydroxysteroid dehydrogenase
B 1 (HSD11B-1) predominantly activates cortisone to cortisol and 11-dehydrocorticosterone (11-DHC) to
corticosterone, although can sometimes drive the opposing (inactivating reaction), and HSD11B-2 (only inactivates
and converts corticosterone to 11-DHC in rodents) in control and MUN rats at embryonic day 20 (E20). Moreover,
we evaluated the expression of nutrient transporters for glucose (SLC2A1, SLC2A3) and amino acids (SLC38A1, 2,
and 4). Our results show that MUN dams displayed significantly increased plasma corticosterone levels compared
to control dams. Further, a reduction in fetal and placental weights was observed in both the mid-horn and
proximal-horn positions. Notably, the placental labyrinth zone, the site of feto-maternal exchange, showed
decreased expression of HSD11B1-2 in both horns, and increased HSD11B-1 in proximal-horn placentas, but no
change in NR3C1. The reduced placental GCs catabolic capacity was accompanied by downregulation of SLC2A3,
SLC38A1, and SLC38A2 expression, and by increased SLC38A4 expression, in labyrinth zones from the mid- and
proximal-horns. In marked contrast to the labyrinth zone, the basal zone, which is the site of hormone production,
did not show significant changes in any of these enzymes or transporters. These results suggest that dysregulation
of the labyrinth zone GC “barrier”, and more importantly decreased nutrient supply resulting from downregulation
of some of the amino acid system A transporters, may contribute to suboptimal fetal growth under MUN.
Background
Glucocorticoids (GCs) are critical for fetal organ growth
and maturation [1,2], though GCs exposure must occur
in a temporally specific pattern. Endogenous (i.e., mater-
nal stress) or exogenous excessive fetal GCs exposure
results in reduced fetal growth, and intrauterine growth
restricted (IUGR) fetuses have an enhanced susceptibil-
ity to hypertension, insulin resistance, and anxiety-
related disorders later in life [3-5]. Impairments in fetal
growth have been attributed to the direct effects of
maternal GCs on the fetus, which prematurely shifts
fetal tissue development from a proliferative state to a
functionally mature state [6]. Normal fetal growth is
dependent on a complex interaction of maternal, pla-
cental, and fetal endocrine signals, and GC-mediated
fetal growth restriction has also been associated with
disturbances in placental growth and function [7,8].
GCs are highly lipophilic, and readily cross placental
membranous barrier by passive diffusion. Actions of
GCs are mediated via intracellular GC receptor
(NR3C1) [9]. During pregnancy high levels of cortisol
(human) [10] and corticosterone (rat) [11] are prevalent
within the maternal circulation. However, maternal GCs
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in GC concentrations between the maternal and fetal
plasma is attributed to the special transport and perme-
ability properties of the placenta [13]. Specifically, the
placenta protects the fetus against maternal cortisol or
corticosterone by 11-hydroxysteroid dehydrogenase
(HSD11B)-mediated enzymatic oxidation of these hor-
mones to their biological inactive forms. To date, two
HSD11B isoforms have been cloned. HSD11B type 1
(HSD11B-1) isoform possesses both oxidase and reduc-
tase activities but functions mainly as a reductase, con-
verting cortisone and 11-dehydrocorticosterone (11-
DHC) to cortisol, and corticosterone, respectively. Con-
versely, HSD11B type 2 (HSD11B-2) acts as an oxidase
that inactivates bioactive cortisol and corticosterone to
inactive cortisone and 11B-hydrocorticosterone. Thus,
HSD11B-2 constitutes a placental GC “barrier” that
could contribute to the modulation of fetal growth.
Although the activity and expression of HSD11B-2
within the placenta correlates with birth weight [14,15]
and HSD11B-2 gene expression is reduced in IUGR rats
and human gestations [14,16], relative changes in
HSD11B-1/2 activity/expression cannot fully character-
ize the amount of active/inactive GCs within the pla-
centa as there is an influx of GCs from maternal [17]
and fetal [18] compartments to the placenta during
pregnancy.
Maternal global undernutrition (MUN), or selective
protein deprivation during pregnancy increase maternal
GCs plasma levels, and reduce fetal and placental
weights [19-21]. Consistent with this, we have shown
that 50% MUN during the second period of pregnancy
(E10-E20) results in reduced placental and fetal weights
at term gestation in rat. We hypothesize that MUN dur-
ing pregnancy associates with increased maternal GCs
levels, and decreased placental HSD11B enzyme as well
reduced placental nutrient transporters with subsequent
negative effects on placental and fetal growth. Our first
objective was therefore to determine the impact of
MUN on maternal GC levels, and on the placental
expression of HSD11B-1/2, and NR3C1 in the basal
zone (site of hormone production) and in the labyrinth
zone (site of maternal-fetal nutrient exchange) from
both mid- and proximal-horn placentas at E20. We
focused on fetuses and placentas from mid- and proxi-
mal-horn positions to evaluate any differential impact by
MUN. The mid-horn (site that receives the lowest level
of maternal blood supply) and proximal-horn (site that
receives the highest level of maternal blood supply)
positions were specifically investigated. Glucose trans-
porters are critical for maintaining the supply of glucose,
the primary substrate for fetal oxidative metabolism, and
sodium-dependent amino acid transport system A is
essential for supplying neutral amino acids to the fetus
[22-24], and both types of transporters are affected by
intracellular levels of GCs in many cell types, including
placental trophoblast cells [25]. Consequently, our sec-
ond objective was to assess the placental changes in the
expression of glucose transporter 1 (SLC2A1, previously
called GLUT1) and glucose transporter 3 (SLC2A3, pre-
viously called GLUT3), together with the three known
system A amino acid transporters SLC38A1, 2, and 4
(previously called SNAT1, 2, and 3) [26] in basal and
labyrinth zones from mid- and proximal-horn placentas
in response to MUN.
Methods
Animals
Studies were approved by the Animal Research Commit-
tee of the Los Angeles BioMedical Research Institute at
Harbor-UCLA (LABioMed), and were in accordance
with the American Association for Accreditation of
Laboratory Care (AALC), and National Institutes of
Health (NIH) guidelines. Eight-week-old first-time-preg-
nant Sprague Dawley rats (230-240 g body weight)
(Charles River Laboratories Inc., CA) were housed in a
facility with constant temperature and humidity, a con-
trolled 12 h light/dark cycle, and an ad libitum diet
(AdLib) of standard laboratory chow (protein 23%, fat
4.5%, metabolizable energy 3030 kcal/kg; Lab Diet 5001,
MO). At embryonic age 10 (E10) based upon day of
expelled plug, dams were randomly allocated to a con-
trol diet (N = 6) in which they were continued on the
AdLib diet or a 50% food-restricted (MUN) diet (N = 6)
that was determined by quantifying normal intake of the
rats that were fed AdLib at the equivalent stage of gesta-
tion. Respective diets were continued throughout the
remainder of gestation. At E20, dams were weighed
before sacrifice.
Maternal blood collection and plasma corticosterone
quantification
Maternal blood obtained by cardiac puncture from
A d L i b( N=6 )a n dM U N( N=6 )d a m sw a sc o l l e c t e d
into heparinized tubes, centrifuged at 9,000 g for 10
minutes at 4°C, and plasma was frozen at -80°C until
use. Maternal plasma corticosterone levels were deter-
mined by radioimmunoassay (Diagnostic Systems
Laboratories Inc., TX) using a highly specific corticos-
terone antiserum, as per manufacturer’s instructions.
The detection threshold was 2.7 ng/ml. The intra- and
inter-assay variations were 2.4 and 4.4%, respectively.
Fetal and placental tissue collections
AdLib (N = 6) and MUN (N = 6) dams were sacrificed
E20 using an overdose of 4% isoflurane. The uterus was
delivered through a mid-line incision, and the gesta-
tional sacs were removed. Fetuses and placentas were
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ine horn. Excess fluid was blotted from the fetuses and
their wet weights obtained using an electronic scale with
an accuracy of ± 0.1 mg (Mettler Instrument Corp,
Model AE50, Hightstown, NJ). Proximal-horn gestations
were those closest to the cervix; mid-horn gestations
were in the middle of the uterine horn. When the num-
ber of fetuses was odd, there was one mid-horn gesta-
tion, whereas when the number of fetuses was even,
there were two mid-horn gestations. We separated pla-
centas from mid and proximal-horn positions to evalu-
ate uterine position (difference in maternal blood
supply) in relation to AdLib or MUN diets. The placen-
tas were dissected into basal and labyrinth zones, the
two morphologically and functionally distinct zones.
Only uterine horns with five to seven fetuses were used.
Placentas were trimmed of membranes and weights
recorded. The two zones were then individually weighed
and flash-frozen in liquid nitrogen for protein
extraction.
Protein extraction, SDS-PAGE, and Western blot analysis
Placentas were separated into basal and labyrinth zones,
and sonicated on ice in the T-PER tissue protein extrac-
tion reagent buffer (Thermo Scientific, IL) that con-
tained protease inhibitors (HALT cocktail, Thermo
Scientific). Protein concentration was determined by
bicinchoninic acid (BCA) solution (Thermo Scientific).
All protein fractions were frozen at -80°C until use.
The effect of MUN on placental expression of
HSD11B-1, HSD11B-2, and NR3C1, and SLC2A1,
SLC2A3, SLC38A1, SLC38A2 and SLC38A4 protein
levels was evaluated by Western blot analysis of the tis-
sue lysates. For each sample, 50 μg of protein were
separated on a 12% polyacrylamide gel (Invitrogen
Corp., CA). A positive control (an aliquot of a cell lysate
with the corresponding antigen overexpressed) was also
loaded with each immunoblot (Table 1). The separated
proteins were transferred electrophoretically to Immobi-
lon-P membranes (BioRad Laboratories, CA). Mem-
branes were incubated in a blocking solution (5%
powdered non-fat milk in Tris buffer saline [TBS] and
0.01% Tween-20 [TBS-T]) at room temperature for 1 h,
and then in the same solution containing a primary
antibody that reacts with HSD11B-1, HSD11B-2,
NR3C1, or one of the nutrient transporters SLC2A1,
SLC2A3, SLC38A1, SLC38A2, and SLC38A4 (see Table
1 for dilutions), at 4°C overnight. After washes in TBS-
T, membranes were incubated with the corresponding
horseradish peroxidase secondary antibody (Table 1) at
room temperature for 1 h followed by washes in TBS-T.
Proteins were visualized by the enhanced chemilumines-
cence signaling system (GE Healthcare, NJ) after which
blots were exposed to autoradiography film. The result-
ing bands were compared by scanning densitometry. To
ensure equal loading, protein blots were stripped and
reprobed with glyceraldehyde-3-phosphate dehydrogen-
ase (GAPDH) (1:1000; Millipore Corp., MA). Placental
GAPDH expression has been previously demonstrated
to remain stable under conditions of MUN [27].
Statistical Analysis
Maternal corticosterone level s ,a n dm a t e r n a l ,f e t a l ,a n d
placental weights, as well as Western blots were ana-
lyzed using NCSS97 software (NCSS, UT). Maternal
corticosterone levels were compared using a two-tailed
Student t-test. Maternal weights were compared using a
one-way analysis of variance (ANOVA). Fetal weights
Table 1 Antibodies used in Western blot analysis
Primary antibodies and their
commercial source
First antibody
dilution
Horse radish peroxidase-linked secondary
antibodies, and their commercial source
Positive controls Secondary
antibody dilution
Rabbit polyclonal
HSD11B-1
(Cayman Ann Arbor, MI)
1:500 Rabbit immunoglobulin G
(Millipore,
Rat liver tissue
lysate
1:2500
Sheep polyclonal
HSD11B-2 (Chemicon,
Temecula, CA)
1:4000 Sheep immunoglobulin G
(Upstate, Temecula, CA)
Rat liver tissue
lysate
1:5000
Rabbit polyclonal
GR (Abcam, Cambridge, MA)
1:3500 Rabbit immunoglobulin G
(Millipore, MA)
Rat liver tissue
lysate
1:2500
Rabbit polyclonal
SLA2C1 (Santa Cruz, CA)
1:700 Rabbit immunoglobulin G (Millipore, MA) H4 cell lysate
(Santa Cruz)
1:2500
Rabbit polyclonal
SLA2C3 (Millipore Corp., CA)
1:700 Rabbit immunoglobulin G
(Millipore Corp., Ca)
SLAC2A3 peptide
(Millipore)
1:2500
Rabbit polyclonal
SLC38A1 (Santa Cruz, CA)
1:700 Rabbit immunoglobulin G
(Millipore Corp., MA)
293T cell lysates
(Santa Cruz)
1:2500
Rabbit polyclonal
SLC38A2 (Santa Cruz, CA)
1:700 Rabbit immunoglobulin G
(Millipore Corp., MA)
U-87MG cell lysates
(Santa Cruz
1:2000
Rabbit polyclonal
SLC38A4 (Santa Cruz, CA)
1:700 Rabbit immunoglobulin G
(Millipore Corp., MA)
293 T cell lysate
(Santa Cruz)
1:2000
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using a two-way ANOVA (with horn positions, and diet
as sources of variation) followed by Tukey-Kramer post
hoc test. Further, placental weights were compared with
a three-way ANOVA (with horn positions, zones, and
diet as causes of variation). When interaction occurs
between these factors, subsequent analyses were carried
out using a one-way ANOVA test. Protein expression in
the labyrinth zone were compared using a two-way
ANOVA (with diet and positions are causes of variation)
followed by Tukey-Kramer post hoc test. Since differ-
ences between zones and placental positions were evi-
dent, data are presented separately for basal and
labyrinth zones, and mid- and proximal-horn placentas.
Correlations between changes in means of maternal GC
levels and fetal or placental weights at term gestation
were performed using Pearson’s correlation coefficient.
Values are expressed as means ± SE and considered sig-
nificant at P < 0.05.
Results
Maternal corticosterone levels
Maternal plasma corticosterone levels were significantly
higher in MUN dams at E20 compared to AdLib dams
(Figure 1A; P < 0.01, Student t-test), consistent with a
maternal stress response.
Maternal weight
Prior to the initiation of MUN (E10), there was no dif-
f e r e n c ei nb o d yw e i g h tb e t w e e nt h eM U Na n dA d L i b
dams (data not shown). At E20, the MUN dams had sig-
nificantly lower body weights compared to those from
AdLib dams (Figure 1B; P < 0.001, one-way ANOVA).
Fetal weight
MUN E20 fetuses from either mid-horn or proximal-
horn placentas weighed significantly less than position-
matched fetuses from AdLib controls (Figure 2A; P <
0.02, two-way ANOVA). In contrast, MUN and AdLib
fetal weights from mid-horn positions were comparable
to the respective fetal weights from proximal-horn posi-
tions (Figure 2A; one-way ANOVA).
Placental zone weights
MUN basal (Figure 2B) and labyrinth (Figure 2C) zones
from either mid-horn or proximal-horn positions
weighed significantly less than AdLib zone- and posi-
tion-matched placentas (P < 0.05, three-way ANOVA).
Among MUN placentas, the basal and the labyrinth
zones from mid-horn placentas weighed significantly
less than zone-matched tissues from proximal-horn sites
(Figure 2B-C; P < 0.05, one-way ANOVA), while uterine
position had no impact on the weights of the two pla-
cental zones in AdLib gestations at E20.
Correlation studies
We assessed the correlation between maternal corticos-
terone levels with fetal or placental weights in MUN
rats. We found a modest inverse correlation between
maternal corticosterone levels with fetal weight (fetal: r
= -0.22), mid-horn placentas (r = -0.36), or proximal-
horn placentas (r = -0.31), though without any statistical
significance.
Placental HSD11B-1 and -2, and NR3C1 protein
expression
For each of the protein, we detected a single immunor-
eactive band of the expected molecular weight on Wes-
tern blots of placental protein lysates (Figure 3A-B). In
the labyrinth zone, the expression of HSD11B-1 (GC
activation) was significantly increased MUN placentas
from proximal-horn compared to position matched-
AdLib controls (Figure 3C; P < 0.05, two-way ANOVA)
and remained statistically significant upon Tukey-Kra-
mer post hoc analysis, whereas HSD11B-2 (GC inactiva-
tion) was significantly lower in MUN labyrinth tissue
from both horns as compared to the AdLib placentas
(Figure 3D; P < 0.05, two-way ANOVA). NR3C1 protein
was similarly expressed in MUN and AdLib specimens
from either mid- or proximal horns (data not shown).
When comparing positions, MUN placental labyrinth
zones from mid-horn placentas did not show any signifi-
cant difference for either HSD11B-1 or HSD11B-2, com-
pared to the respective proximal-horn placentas using
one-way ANOVA. In contrast, in the AdLib, HSD11B-2
expression was significantly decreased in the labyrinth
zone of mid-horn placentas, compared to the zone-
matched proximal-horn placentas (Figure 3D; P < 0.05,
one-way ANOVA).
In the basal zone, expression levels HSD11B-1,
HSD11B-2, and NR3C1 proteins from either mid-horn
or proximal-horn positions were unchanged in MUN
and compared to AdLib controls (results not shown).
a
(A)                                                                 (B)
a
Figure 1 Maternal corticosterone levels and weight in MUN
and AdLib dams at E20 gestation. Maternal serum corticosterone
levels (B) in MUN (black bars) and AdLib (open bars) dams at E20.
a
indicates a significant difference between zone weights from MUN
vs. AdLib.
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As GCs affect both placental glucose [22] and amino
acid [28] transporter systems, we determined the expres-
sion levels of facilitative glucose transporters SLC2A1
and SLC2A3, and neutral amino acids transporters
SLC38A1, SLC38A2 and SLC38A4 proteins. For each of
these proteins, we detected a single immunoreactive
band of the expected molecular weight on Western
blots of placental protein lysates (Figures 4A-B, 5A-C).
In the labyrinth zone, SLC2A1 expression was signifi-
cantly upregulated in the proximal-horn (Figure 4C; P <
0.04, two-way ANOVA) but unchanged in mid-horn
placentas from MUN dams, compared to the respective
AdLib zones from mid-horn or proximal-horn placentas.
In the basal zone, SLC2A1 was unchanged in either
mid-horn, or proximal-horn placentas of MUN dams
compared to the respective AdLib zones from mid-horn
or proximal-horn placentas (results not shown). Since
previous studies have shown that SLC2A3 is not
expressed in the basal zone in rat [29], we quantified
SLC2A3 expression in the labyrinth zone only. SLC2A3
was significantly downregulated in the labyrinth zones
from either MUN mid- or proximal-horn compared to
the respective AdLib zones from mid-horn or proximal-
horn placentas (Figure 4D; P < 0.05, two-ANOVA).
When comparing positions, MUN placental labyrinth
zones from mid-horn placentas did not show any signifi-
cant difference for either SLC2A1 or SLC2A3, compared
to the respective proximal-horn placentas. Conversely,
in the AdLib placentas, SLC2A1 expression was signifi-
cantly increased in the labyrinth zone from mid-horns,
compared to the proximal-horn positions (Figure 4C; P
< 0.05, one-way ANOVA).
Similarly to SLC2A3, SLC38A1 and SLC38A2 proteins
were significantly decreased in the MUN labyrinth zone,
though not in the MUN basal zone, of either mid-horn
a a
(A)                                                            
(B)                                                                    (C)
a
a, b
a
a, b
Fi 2
Figure 2 Fetal and placental weights. Fetal body weights from MUN and AdLib mid- and proximal-horns (A). Placental basal (C) and labyrinth
(D) weights from MUN (black bars) and AdLib (open bars) mid- and proximal-horns.
a indicates a significant difference between zone weights
from MUN vs. AdLib.
bindicates a significant difference between proximal- and mid-horn placental positions.
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AdLib zones from mid-horn or proximal-horn placentas
(Figure 5D-E; P < 0.05, two-way ANOVA). Conversely,
SLC38A4 was significantly increased in the MUN labyr-
inth zone, of either mid-horn or proximal-horn placen-
tal positions compared to AdLib zones from mid-horn
or proximal-horn placentas (Figure 5F; P < 0.05, two-
way ANOVA) and remained statistically significant
upon Tukey-Kramer post hoc analysis. MUN basal zone
expression of SLC38A4 was unchanged at either uterine
position.
When comparing positions, MUN placental labyrinth
zones from mid-horn placentas exhibited significantly
lower SLC38A1 protein expression, compared to the
labyrinth zone of proximal-horn placentas (Figure 5D; P
< 0.05, one-way ANOVA). Similarly, in AdLib placentas,
SLC38A1 expression levels were significantly lower in
the labyrinth zone of mid-horn compared to zone-
matched proximal-horn placental positions (Figure 5D-
E; P < 0.05, One-way ANOVA). Moreover, in MUN pla-
centas, labyrinth zones from mid-horn placentas
exhibited significantly lower SLC38A2 protein expres-
sion, compared to the labyrinth zones of proximal-horn
placentas. Similarly, SLC38A2 expression levels in AdLib
placentas were significantly lower in mid-horn compared
to zone-matched proximal-horn placental positions (Fig-
ure 5D-E; P < 0.05, One-way ANOVA). Notably,
SLC38A4 expression levels in either MUN or AdLib pla-
cental zones were unchanged in mid- vs. proximal-horn
placental positions (Figure 5F).
Discussion
This study addressed the impact of an MUN-mediated
maternal stress and nutrient response on fetal and pla-
cental development in rats between E10-E20. Maternal
food restriction produced a predictable stress response
in the mother, as evidenced by elevated maternal plasma
corticosterone, and a reduction in fetal weight and
hypotrophy of the basal and labyrinth zones of the pla-
centa. The reduction in fetal and placental weights was
observed in both mid- and proximal-horn positions, the
uterine regions which receive the least and greatest
Figure 3 Effects of MUN on the level of HSD11B-1 and HSD11B-2 protein expression in labyrinth zone from mid- and proximal-horn
placentas. Representative immunoblots of HSD11B-1 (A) and HSD11B-2 (B) protein expression. Densitometric analysis of HSD11B-1 (C) and
HSD11B-2 (D) protein expression.
a indicates a significant difference between zone weights from MUN (black bars) vs. AdLib (open bars).
bindicates a significant difference between proximal- and mid-horn placental positions.
Belkacemi et al. Reproductive Biology and Endocrinology 2011, 9:105
http://www.rbej.com/content/9/1/105
Page 6 of 11Figure 4 Effects of MUN on the level of SLC2A1 and SLC2A3 protein expression in labyrinth zone from mid- and proximal-horn
placentas. Representative immunoblots of SLC2A1 (A) and SLC2A3 (B) protein expression. Densitometric analysis of SLC2A1 (C) and SLC2A3 (D)
protein expression.
aindicates a significant difference between zone weights from MUN (black bars) vs. AdLib (open bars).
bindicates a significant
difference between proximal- and mid-horn placental positions.
Figure 5 Effects of MUN on the level of SLC38A protein expression in labyrinth zone from mid- and proximal-horn placentas.
Representative immunoblots of SLC38A1 (A), SLC38A2 (B) and SLC38A 4 (C) protein expression. Densitometric analysis of SLC38A1 (D), SLC38A2
(E), and SLC38A4 (F) protein expression.
a indicates a significant difference between zone weights from MUN (black bars) vs. AdLib (open bars).
bindicates a significant difference between mid- and proximal-horn placental positions.
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nificant changes in placental tissue occurred in the pla-
cental labyrinth zone. Labyrinth tissue, which mediates
feto-maternal nutrient exchange, exhibited decreased
expression of HSD11B-2, the enzyme that oxidizes and
deactivates corticosterone to 11-dehydrocorticosterone
(cortisol to cortisone in humans). In addition, MUN pla-
centas expressed increased HSD11B-1, the reductase
that produces corticosterone (cortisol in humans), in
proximal-horn placentas. There was no change in
NR3C1 expression at either uterine position. Nutrient
transporters, including SLC38A1 and SLC38A2 were
significantly downregulated in MUN placental labyrinth
zone from either mid- or proximal-horns. Conversely,
SLC38A4 was upregulated in the labyrinth zone from
both placental positions. In marked contrast to the
labyrinth zone, the basal zone did not show changes in
any of these metabolizing enzymes or transporters. Col-
lectively, our results suggest that the increase in mater-
nal GCs following MUN-mediated stress is associated
with both dysregulation of the placental GC barrier and
the decrease in overall maternal nutrients availability to
the fetus leading to suboptimal fetal growth. Although,
placental transport of selective nutrient to the fetus may
still be increased if SLC2A3 and SLC38A4 were the
major contributors, but this did not prevent fetal weight
loss in the MUN gestations.
Higher levels of maternal GCs and downregulation of
HSD11B-2, may disrupt several essential developmental
processes [6], including placenta through increased
local GC levels that will affect placental weight and
development. Thus, it is possible that the compromised
placental weight we observed under MUN is mediated,
in part, by the HSD11B-2 downregulation, and the
resulting oversupply of corticosterone to the placenta.
In support of this, HSD11B-2 knockout mice
(HSD11B-2-/-) result in substantially smaller placentas
than congenic littermate controls (HSD11B-2+/+) from
HSD11B-2+/- crosses [4]. Although the loss of the
HSD11B-2 enzyme may be sufficient to cause placental
hypotrophy without a direct maternal contribution,
increased maternal GCs may exacerbate these effects
on the placenta. However, in our study we found only
a modest inverse correlation between maternal corti-
costerone levels, and MUN placental weights, suggest-
ing a rather limited effect of increased maternal GCs
on placental growth. It is therefore possible that any
increase in placental corticosterone following MUN
insult may result, at least partially, from the downregu-
lation of HSD11B-2 expression/activity, and or overex-
pression/ hyperactivity of HSD11B-1. Although,
additional experiments are required to differentiate the
contribution of the two HSD11B isoforms on placental
weight and function.
Contrary to our findings, Lesage et al. [30] found that
normalization of maternal corticosterone levels by adre-
nalectomy plus corticosterone supplementation in a rat
MUN model with reduced HSD11B-2 expression did
not affect placental growth. The discrepancies in these
observations may be due to differences in methodology,
as we specifically controlled for placental location (mid-
and proximal-horns) whereas Lesage’ss t u d yd i dn o t
control for placental position. Alternatively, the growth
restriction in the MUN placentas may rather stem from
lack of maternal nutrients, or some other MUN-acti-
vated signaling pathways. Consistent with this, rat dams
fed low protein diet (an insult that has similarities with
MUN), or fed 50% MUN (identical to our study) have
increased corticosterone levels [19-21], and decreased
placental weight as well as placental HSD11B-2 expres-
sion [19,20]. Interestingly, in sheep, elevated maternal
plasma cortisol concentrations following 10 days MUN
in late gestation did not persist when the duration of
MUN was extended to 20 days nor did it affect placental
weight, suggesting an adaptation to a new plan of nutri-
tion over time [21]. It is worth noting that these studies
and our’s did not discriminate between the contribution
of increased maternal GCs and MUN to the observed
experimental endpoints, and both parameters may alter
placental development either independently or in con-
cert. Hence, the signaling mechanisms leading to
HSD11B-2 underexpression and in some regions
HSD11B-1 overexpression and subsequent placental
growth restriction in the MUN pregnancies warrant
further study.
As reduced placental MUN labyrinth zone weight sug-
gested an impaired placental nutrient transport capacity,
we examined the expression of glucose and amino acid
transporters. SLC2A1 and SLC2A3 glucose transporter
proteins were divergently regulated in the labyrinth zone
of MUN rats. The upregulation of SLC2A1 in the labyr-
inth zone from the proximal-horn placenta implies an
increase in glucose transport capacity that may be a
compensatory mechanism to raise fetal glucose supply,
as SLC2A1, which is normally localized at the site of
entry and exit in the placental barrier, facilitates
materno-fetal glucose transport [31]. Conversely, the
unchanged SLC2A1 expression in the labyrinth zone
from the mid-horn may not be influenced by MUN.
Reduced SLC2A3 expression in MUN placentas was
reported previously [30], and our findings are consistent
with their results. Thus, it is possible that under MUN
conditions, SLC2A3, which has a lower Km (1.8 mM)
for glucose compared to SLC2A1 Km (2-5 mM)[ 3 2 - 3 4 ]
may be more sensitive to intracellular variations of glu-
cose concentrations, compared to SLC2A1. Alterna-
tively, the decrease in SLC2A3 in the MUN placentas
could be a protective measure to limit glucose transport
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Page 8 of 11out of the placenta [30]. Since the fetus is almost
entirely dependent on maternal glucose passing through
the placenta, inadequate transplacental passage of glu-
cose for an extended period of time will likely affect
fetal growth and development. The decrease in the
expression of the amino acid transporters SLC38A1 and
SLC38A2 in the labyrinth zone may further impair fetal
growth. Unlike SLC38A1/2,S L C 3 8 A 4e x p r e s s i o nw a s
upregulated in the labyrinth zone from both horns,
which may again reflect a compensatory mechanism
aimed at limiting amino acid clearance [15]. Whether
transporters dysregulation in the MUN placentas is
solely due to MUN or oversupply of corticosterone fol-
lowing MUN, or both remains to be investigated.
Analysis of transporter expression by position within
the horns showed significantly lower SLC38A1 protein
expression in MUN mid-horn placentas compared to
proximal-horn placentas, possibly due to differences in
maternal blood supply [34] or levels of local corticoster-
one or both. This difference may also reflect a more
pronounced dysfunction of certain protein from system
A in the mid-horn position. Conversely, SLC2A1 and
SLC38A2 expression upregulation in placental AdLib
labyrinth zone from mid- compared to proximal-horn
positions, may represent a compensatory mechanism.
Whereas lower SLC38A1 expression mid-horn placentas
compared to proximal-horn placentas may associate
with differences in maternal blood supply in the AdLib.
Overall, our results demonstrate zone-specific and cer-
tain position-specific changes in amino acid transporter
expression in MUN placentas, resulting in impaired pla-
cental growth and most likely in placental dysfunction.
The positional difference in the AdLib placentas may
suggest the existence of compensatory mechanisms.
Maternal plasma corticosterone levels were negatively
correlated with MUN fetal weights at term gestation but
without significance, implying that MUN fetal weight
reduction may not result from a direct increase in
maternal corticosterone. In support of our findings
Lesage et al. [30] study demonstrated that MUN
induced IUGR similarly in both normal and in pre-adre-
nalectomized MUN rats supplemented with control
levels of corticosterone. These investigators also
reported elevated plasma corticosterone in rat fetuses
from MUN gestations, as well as decreased fetal adrenal
weight and decreased adrenocorticotropic hormone
(ACTH) levels, suggesting suppression of intrinsic fetal
adrenal corticosterone production [21]. Their findings
indicate that perhaps the fetal growth restriction in the
MUN fetus was not associated with a direct increase in
GCs. Based on these findings; we speculate that
decreased nutrient transport following downregulation
GCs exposure?
IUGR fetus
Maternal corticosterone levels
- HSD11B-1
- HSD11B-2  
- SLC2A1
- SLC2A3
- SLC38A1
- SLC38A2
- SLC38A4
Protein  expression  in the 
MUN labyrinth zone from 
proximal-horn placenta
IUGR newborn
- HSD11B-1
- HSD11B-2  
- SLC2A1
- SLC2A3
- SLC38A1
- SLC38A2 
- SLC38A4
Protein  expression  in the 
MUN labyrinth zone from 
mid-horn placenta
Cervix
Nutrient intake 
Nutrient availability?
Figure 6 Increased maternal corticosterone levels and altered placental labyrinth zone expression of HSD11B enzymes and nutrient
transporters in undernourished rat gestations at E20.
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Page 9 of 11of SLC38A1/2, may be the main contributor to the fetal
growth restriction in the MUN pregnancies. In support
of our data Jansson et al. [35] showed that decrease pla-
cental amino acid transport precedes IUGR, and hence
is probably a contributing cause rather than just a sec-
ondary consequence of it.
In summary, suboptimal maternal nutrition enhances
maternal GCs production, reduces placental weight and
placental expression of HSD11B-2 as well as nutrient
transporters, all of which may contribute to compro-
mised fetal growth (Figure 6). Because maternal GCs
modestly correlated with decreased fetal weight in the
MUN fetuses, we speculate that the MUN-decreased
fetal growth could be related, mainly, to disruption of
placental transfer of nutrients and/or disturbance of
their use by fetal tissues (Figure 6). However, this study
does not rule out the possibility that maternal GCs may
participate indirectly in programming processes that
contribute to fetal suboptimal growth. The insult on the
mid-horn placentas did not translate into more severe
effect on the corresponding fetus as there was no signifi-
cant difference between MUN fetuses from mid-horn vs.
proximal-horn positions, which may indicate a compen-
satory mechanism. Subsequent reduction in newborn
weights associates with a higher incidence of metabolic
syndromes in adulthood [34]. Remarkably, hypertension
caused by maternal dietary protein restriction can be
prevented by pharmacological blockade of GC biosynth-
esis in pregnant rats and offsprings [35], implicating GC
inhibitors as a therapeutic tool to improve placental and
birth defects associated with undernutrition during preg-
nancy. In our model, since maternal GCs may have lim-
ited direct impact on fetal growth, improved maternal
dietary intake alone may prevent or ameliorate subopti-
mal placental and fetal growth in MUN gestations.
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